Growth Metrics

Neogenomics (NEO) Non-Current Deferred Tax Liability (2016 - 2025)

Neogenomics (NEO) has disclosed Non-Current Deferred Tax Liability for 13 consecutive years, with $20.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Deferred Tax Liability fell 8.45% year-over-year to $20.8 million, compared with a TTM value of $20.8 million through Sep 2025, down 8.45%, and an annual FY2024 reading of $103.1 million, up 324.58% over the prior year.
  • Non-Current Deferred Tax Liability was $20.8 million for Q3 2025 at Neogenomics, up from $20.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $143.1 million in Q4 2021 and bottomed at $1.7 million in Q1 2021.
  • Average Non-Current Deferred Tax Liability over 5 years is $41.1 million, with a median of $28.8 million recorded in 2023.
  • The sharpest move saw Non-Current Deferred Tax Liability plummeted 89.35% in 2021, then skyrocketed 2864.97% in 2022.
  • Year by year, Non-Current Deferred Tax Liability stood at $143.1 million in 2021, then plummeted by 75.71% to $34.8 million in 2022, then plummeted by 30.12% to $24.3 million in 2023, then soared by 324.58% to $103.1 million in 2024, then tumbled by 79.78% to $20.8 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for NEO at $20.8 million in Q3 2025, $20.0 million in Q2 2025, and $21.0 million in Q1 2025.